Cambridge Investment Research Advisors
NPTN

Cambridge Investment Research Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-75,379
Closed -$819K – 1672
2015
Q4 		$819K Buy
+75,379
New +$681K 0.02% 624

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Cambridge Investment Research Advisors's NPTN Position: Q1 2016 in Review

Cambridge Investment Research Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q1 2016, closing a stake of 75,379 shares — an estimated $819K sold.

Cambridge Investment Research Advisors first reported a position in NPTN in Q4 2015 and held it in 1 quarter. The position peaked at $819K in Q4 2015. 132 funds tracked by Wall St. Rank hold NPTN as of Q1 2016.

  • Cambridge Investment Research Advisors reported no remaining NEOPHOTONICS CORP position as of Q1 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 75,379 NEOPHOTONICS CORP shares in Q1 2016, an estimated $819K.
  • Cambridge Investment Research Advisors first reported a position in NEOPHOTONICS CORP in Q4 2015 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's NEOPHOTONICS CORP position peaked at $819K in Q4 2015.
  • 132 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.